by Lucia Mueller, President, PharmacyChecker.com | Oct 12, 2017 | Advocacy, Drug Prices, Online Pharmacies, Policy, Your Stories
PharmacyChecker.com is proud of the work we do to advocate for your access to affordable medication, and we welcome you, your sister, and your sister’s husband’s cousin to join us!
The greed of pharmaceutical companies has become overbearing: not only their price gouging, but rampant public relations and lobbying campaigns attempt to muzzle the majority of Americans who demand lower drug prices.
(more…)
Tagged with: Advocacy, Drug Prices, Lower Drug Prices
by Lucia Mueller, President, PharmacyChecker.com | Sep 27, 2017 | Online Pharmacies
I’m from a small town outside of Houston, Texas called Wallis. To my New Yorker friends, Wallis may appear “rural,” but, with a trip downtown clocking in at 35 minutes on sprawling Texas tollways, it’s not exactly that far from essential medication, not to mention some of the nation’s best hospitals. Despite slipping in some not-so-sneaky boasting, I’m concerned about the millions of Americans who live in rural areas who cannot access the prescription medications they need.
For years, rural residents in the U.S. have faced even greater obstacles to health care than their urban friends, and that includes problems (more…)
Tagged with: Houston, Online Pharmacy, Rural Areas, Texas
by Lucia Mueller, President, PharmacyChecker.com | Sep 15, 2017 | Advocacy, Drug Prices, Insulin
There is profound frustration and anger reverberating throughout the diabetic community due to the skyrocketing prices of insulin in the United States. Pharmaceutical companies like Novo Nordisk, Eli Lilly and Sanofi are charging out-of-reach prices for insulin medications necessary for diabetics’ survival.
On September 9th, 2017, over forty people gathered outside of Eli Lilly headquarters in Indianapolis to make a statement on behalf of American citizens living with diabetes and, in actuality, all Americans who face the highest drug prices in the world.
(more…)
Tagged with: #insulin4all, Big Pharma, diabetes, Drug Prices, Eli Lilly, Insulin, Novo Nordisk